History and Geography
One of the best accounts on the geography of DM, published in the British Medical Journal in 1907, was a symposium on diabetes in the tropics, which was chaired by Richard Havelock-Charles.
The authors reviewed within- and between-country differences in the prevalence of diabetes. It was noted, for example, that diabetes was more common in Bengal than in upper India, and was less common in Sudan and the Cameroons than in Europe. Papers also indicated the rarity of diabetes in Japan and China. In 1908 Robert Saundby reviewed differences in the prevalence Ofdiabetes in Europe. Richard T. Williamson in 1909 reported high rates of DM in Malta, which were substantiated in later works. He also noted that there were low rates in Cyprus, Hong Kong, Malaya, Aden, Sierra Leone, British Honduras, Cuba, Labrador (Eskimos), Fiji, and certain populations of Asian Indians and Chinese. In addition, he summarized available evidence on rates by time and place in many European populations. In 1922 Fredrick L. Hoffman published data on mortality rates due to DM for 15 countries or regions for persons over the age of 20. These rates ranged from 67.8 per 100,000 in Malta to 8.6 in Italy. The extensive data on the epidemiology of diabetes of Emerson and Larimore published in 1924 included mortality statistics by geographic region. Comparative mortality data were also published in the many editions of Joslin’s Treatment OfDiabetes Mellitus. In the 1930s, there were many reports showing very low rates of diabetes among Eskimos and American Indians. Other pioneering studies on the prevalence in other European populations between 1916 and 1952 have been summarized by Silwer (1958).Modern observations of geographic differences began with the publication of S. M. Cohen’s (1954) paper showing marked differences in diabetes rates among Amerindian tribes.
This was followed shortly by J. G. Cosnetfs (1957) work describing very high rates of diabetes in Asian Indian immigrants to South Africa. These rates were 30 to 40 times higher than among black South Africans. Diabetes Mellitus in the Tropics (1962), by J. A. Tulloch, summarized much of the evidence on the prevalence of diabetes in developing and developed countries.Attempts to standardize definitions and criteria began when the International Diabetes Federation held its first conference in 1952. The National Diabetes Data Group published the presently used classification of diabetes in 1979, and in 1980 the World Health Organization Expert Committee on Diabetes Mellitus published a second report standardizing definitions and criteria for DM and imparied glucose tolerance. One good example of these international efforts is the work edited by J. I. Mann, K. Pyorala, and A. Teuschner in 1983 covering epidemiology, etiology, clinical practice, and health services throughout the world. In 1985, the National Diabetes Data Group published Diabetes in America.
Data in Tables VIΠ.34.2 and VIΠ.34.3 show contemporary prevalence figures for different countries and, in some cases, distinguish between urban and rural populations. Virtually all of these figures were derived from actual determination of the concentration of blood glucose, either fasting or after an oral glucose challenge.
Many migrant populations have been especially prone to high rates of diabetes. For example, Jews have shown an increased susceptibility to diabetes in native European enclaves as well as in various migrant groups. It was noted that Jews in New York City had rates 10 times higher than other U.S. ethnic groups. A number of studies from the early 1900s show high rates of diabetes among Jews in Budapest, Bengal, Boston, and Cairo. More recently, studies have shown that Sephardic Jews in Zimbabwe and Turkey have high rates of diabetes. Migration of Jewish people to and from Israel has produced many different ethnic subgroups.
Newly immigrant Yemenites and Kurds to Israel show lower rates than long-time residents of the same ethnic groups. A. M. Cohen and colleagues, publishing in 1979, found that in a 20-year period there was an increase from 0.06 percent to 11.8 percent in the prevalence of diabetes found among Israeli Yemenites. Medalie and co-workers, studying various ethnic groups in 1975 in Israel, found that European-born Jews had a lower incidence of diabetes than those boro in Africa, Asia, or Israel. They found that obesity was a significant predictor of the prevalence of diabetes among these Israeli ethnic groups.Early reports for Chinese populations indicate a very low prevalence of diabetes, and in fact, Saundby in 1908 observed that none of his colleagues had ever seen a case of diabetes in a Chinese patient. In modern China, the rates remain very low, ranging from 0.2 percent to 1.2 percent. Most authors conclude that the Chinese have a reduced susceptibility to diabetes, although rates are somewhat higher in immigrant Chinese populations in Hawaii (1.8 percent), Singapore (1.6 percent), and Malaya (7.4 percent). The Japanese, like the Chinese, also show a very low prevalence of diabetes in their native countries. However, with migration, the Japanese in Hawaii and California have also showed increased rates of DM.
Amerindians, in particular, have very high rates of diabetes. The highest rates occur among the southwestern Indian groups, with the Pima Indians exhibiting the highest rate (35 percent) of DM. Yet the high rates among Amerindians appear to be recent. Early reports (using different testing methods, of course) indicated very low prevalence of diabetes among North American Indian groups at the turn of this century. Moreover, rates among South American Indian groups still tend to be low.
Other aboriginal groups also seem to be particu- Iarly prone to diabetes, among them Polynesians and Micronesians. Rates are somewhat lower among Melanesians.
Hawaiians have a diabetes rate seven times higher than Caucasians in Hawaii. Among New World black populations in the West Indies and in the United States, there is a high prevalence of type II diabetes, particularly among women. Michael Stem and other researchers have documented high rates of diabetes among Mexican Americans.One explanation of the high frequency of type II DM among certain of these populations is that they developed a highly efficient carbohydrate metabolism under traditional life-styles of a feast and famine cycle. The thrifty mechanisms of carbohydrate metabolism, however, became detrimental with rapidly changing life-styles associated with a decrease in physical activity, an increase in energy in the diet, a reduction of dietary fiber, an increase of refined carbohydrates, and an increase in psychosocial stress.
Among Asian Indians, diabetes rates are low. The overall prevalence of diabetes in India is approximately 2 percent. Diabetes is more prevalent among urban populations, the rich, and the professional classes. In Indian men there also is a north-to-south gradient of diabetes prevalence, with thrice the prevalence in the south.
Yet like other migrant groups, Asian Indian migrants to other countries show high prevalence rates compared to those of indigenous populations. For example, in South Africa only 1 to 4 percent of blacks had DM compared to 17 to 32 percent of Asian Indians. High rates have also been reported from East Indian populations in Fiji, Trinidad, and Singapore. The Indians in South Africa, in particular, were brought over as indentured servants and had a life-style not dissimilar to those of New World black populations. A diabetes-thrifty genotype may have been selected for in these populations as well.
Among black Africans DM is still comparatively rare. Nevertheless, increased prevalence has been noted by Tulloch for urban Africans in a number of nations. Apparently, for susceptible genotypes, the life-style changes associated with rural-to-urban migration result in higher relative risks for type II diabetes.
It is important to note that there is a great deal of genetic heterogeneity among socially designated racial and ethnic groups. This heterogeneity should not be ignored when looking at the environmental or geographic factors that lead to increases in the relative risks for type ∏ diabetes.
The foregoing historical and geographic data indicate that we may anticipate an increase in the worldwide prevalence of DM. The focus has been and remains on treatment of hyperglycemia and the vascular complications of long-term diabetes. Using the epidemiological data and historical perspectives, we are now beginning to develop better programs aimed at early intervention and prevention.
Leslie Sue Lieberman